衰弱对ICU入住后3年生存的影响随体重指数升高而变化:一项基于登记数据的回顾性研究
该研究基于澳大利亚新西兰重症监护学会成人患者数据库,回顾性纳入2018年1月1日至2022年3月31日期间1170个ICU中16岁及以上、有临床衰弱量表(CFS)和BMI记录的成年患者共282586例,其中衰弱(CFS 5-8)49070例(17.4%)。主要终点为ICU入住后3年生存率。校正关键混杂因素后,衰弱与3年生存率降低相关(47.5% vs 82.2%),死亡风险升高(HR 1.67,95%CI 1.62-1.73)。衰弱与生存的关联在不同BMI间不一致:以BMI 18.5-24.9 kg/m²为参照,BMI越高,衰弱伴随的死亡风险增幅越大;BMI低于18.5 kg/m²时BMI对衰弱与死亡的关系无影响。
要点
- 衰弱(CFS 5-8)患者3年生存率47.5%,无衰弱者82.2%,校正后死亡风险HR 1.67(95%CI 1.62-1.73)。
- 衰弱患病率在BMI低于18.5 kg/m²者中最高(34.8%),随BMI升高而下降,BMI≥40 kg/m²时又回升至18.8%。
- 以BMI 18.5-24.9 kg/m²为参照,BMI越高,衰弱伴随的死亡风险增幅越大。
- BMI低于18.5 kg/m²时,BMI对衰弱与死亡的关系无影响。
- 上述关联在多项敏感性分析中保持一致。
适用人群与场景
- 澳大利亚新西兰1170个ICU在2018年1月1日至2022年3月31日收治的16岁及以上成人重症患者
- 需有临床衰弱量表(CFS)评分和BMI记录
诊断标准与关键阈值
- 衰弱定义:临床衰弱量表(CFS)评分5-8分;对照为无衰弱者
- BMI分组以18.5-24.9 kg/m²为参照组
研究设计与关键结果
- 研究类型:基于澳大利亚新西兰重症监护学会成人患者数据库的回顾性多中心登记观察性研究,共1170个ICU、282586例患者,衰弱49070例(17.4%)。
- 主要终点:ICU入住后3年生存率;衰弱者47.5% vs 无衰弱者82.2%,死亡风险HR 1.67(95%CI 1.62-1.73)。
- 衰弱患病率:BMI低于18.5 kg/m²者34.8%,随BMI升高而下降,BMI≥40 kg/m²者18.8%。
- 以BMI 18.5-24.9 kg/m²为参照,BMI越高,衰弱伴随的死亡风险增幅越大;BMI低于18.5 kg/m²时BMI对衰弱与死亡的关系无影响。
- 上述关联在多项敏感性分析中保持一致。
证据类型、等级与局限
- 证据类型:回顾性、多中心、基于登记数据的观察性研究
- 局限:原文未报告局限性
对床旁实践的改变
- 对ICU收治的成人患者,可同时记录CFS评分与BMI,以识别衰弱合并高BMI这一死亡风险增幅更大的人群;作者认为该发现可能对肥胖、衰弱与重症并存时的管理有启示。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Frailty is associated with poorer outcomes in critical illness, but it is unclear if this relationship is consistent across different body mass index (BMI) levels.
DESIGN: A retrospective multicentric registry-based observational study using the Australia New Zealand Intensive Care Society Adult Patient Database.
SETTING: Criticallly ill patients admitted to 1170 ICUs between January 1, 2018, and March 31, 2022.
PATIENTS: All adults aged 16 years and older with a documented Clinical Frailty Scale (CFS) and BMI.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The primary outcome was survival up to 3 years following ICU admission. We used Cox proportional hazards models, linear and nonlinear regression models to investigate the association between frailty (defined as CFS, 5-8), in reference to those without frailty, and the mortality risk up to 3 years, and whether this association varied with BMI, after adjusting for key confounders. We included 282,586 patients, of whom 49,070 (17.4%) were frail. Frailty was most prevalent in patients with BMI less than 18.5 kg/m 2 (34.8%), became less frequent as BMI increased, and more prevalent again in BMI greater than or equal to 40 kg/m² (18.8%). Overall, frailty was associated with lower 3-year survival (47.5% vs. 82.2%) and increased mortality (hazard ratio, 1.67; 95% CI, 1.62-1.73). However, the association between frailty and survival was not uniform. The concomitant presence of frailty was associated with progressively larger increases in mortality as BMI categories increased beyond the reference group of 18.5-24.9 kg/m 2 . There was no effect of BMI on the relationship between frailty and mortality for BMI less than 18.5 kg/m 2 . This relationship was consistent in multiple sensitivity analyses.
CONCLUSIONS: The association between frailty and outcomes after critical illness differed across BMI categories with a larger increase in the risk of mortality noted at higher BMI levels. Our findings may have implications for managing concurrent obesity, frailty, and critical illness.
参考来源
- Subramaniam A, Ling RR, Ueno R, et al. The Varying Impact of Frailty With Increasing Body Mass Index on Survival Up To 3 Years After ICU Admission: A Retrospective Registry-Based Study. Crit Care Med. 2025. PMID: 40637500. doi:10.1097/CCM.0000000000006773
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。